Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 436429, 7 pages
http://dx.doi.org/10.1155/2014/436429
Research Article

Metallothionein-II Inhibits Lipid Peroxidation and Improves Functional Recovery after Transient Brain Ischemia and Reperfusion in Rats

1Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, Avenida Insurgentes Sur No. 3877, 14269 México City, DF, Mexico
2Laboratorio de Neuroprotección, Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Mexico
3Laboratorio de Neuropatología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, Mexico
4Departamento de Sistemas Biológicos de la Universidad Autónoma Metropolitana, Unidad Xochimilco México, Mexico

Received 14 November 2013; Revised 4 January 2014; Accepted 17 January 2014; Published 25 February 2014

Academic Editor: Verónica Pérez de la Cruz

Copyright © 2014 Araceli Diaz-Ruiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mukherjee and C. G. Patil, “Epidemiology and the global burden of stroke,” World Neurosurgery, vol. 76, no. 6, pp. S85–S90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Centers for Disease Control and Prevention (CDC), “Prevalence of stroke—United States, 2006–2010,” Morbidity and Mortality Weekly Report, vol. 61, no. 20, pp. 379–382, 2012. View at Google Scholar
  3. Z. Liu, W. Zhao, T. Xu, D. Pei, and Y. Peng, “Alterations of NMDA receptor subunits NR1, NR2A and NR2B mRNA expression and their relationship to apoptosis following transient forebrain ischemia,” Brain Research, vol. 1361, pp. 133–139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Pluta, R. Rak, D. A. Wink et al., “Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury,” Neurosurgery, vol. 48, no. 4, pp. 884–893, 2001. View at Google Scholar · View at Scopus
  5. W. Xia, J. Han, G. Huang, and W. Ying, “Inflammation in ischaemic brain injury: current advances and future perspectives,” Clinical and Experimental Pharmacology and Physiology, vol. 37, no. 2, pp. 253–258, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. H. Chan, K. Niizuma, and H. Endo, “Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival,” Journal of Neurochemistry, vol. 109, supplement 1, pp. 133–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Diaz-Ruiz, C. Zavala, S. Montes et al., “Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats,” Journal of Neuroscience Research, vol. 86, no. 15, pp. 3410–3419, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ebadi and S. Swanson, “Characterization of metallothionein-like protein in rat brain,” Experientia, vol. 52, pp. 289–291, 1987. View at Google Scholar · View at Scopus
  9. M. Penkowa and J. Hidalgo, “Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis,” Journal of Neuroscience Research, vol. 72, no. 5, pp. 574–586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Yanagitani, H. Miyazaki, Y. Nakahashi et al., “Ischemia induces metallothionein III expression in neurons of rat brain,” Life Sciences, vol. 64, no. 8, pp. 707–715, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. P. Hwang, H. G. Kim, E. H. Han, and H. G. Jeong, “Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner,” Toxicology and Applied Pharmacology, vol. 231, no. 3, pp. 318–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-J. Lee and J.-Y. Koh, “Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes,” Molecular Brain, vol. 3, no. 1, article 30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Trendelenburg, K. Prass, J. Priller et al., “Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia,” Journal of Neuroscience, vol. 22, no. 14, pp. 5879–5888, 2002. View at Google Scholar · View at Scopus
  14. K. Wakida, M. Shimazawa, I. Hozumi et al., “Neuroprotective effect of erythropoietin, and role of metallothionein-1 and -2, in permanent focal cerebral ischemia,” Neuroscience, vol. 148, no. 1, pp. 105–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Penkowa and J. Hidalgo, “Metallothionein treatment reduces proinflammatory cytokines IL-6 and TNF-α and apoptotic cell death during experimental autoimmune encephalomyelitis (EAE),” Experimental Neurology, vol. 170, no. 1, pp. 1–14, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Arellano-Ruiz, C. Rios, H. Salgado-Ceballos et al., “Metallothionein-II improves motor function recovery and increases spared tissue after spinal cord injury in rats,” Neuroscience Letters, vol. 514, no. 1, pp. 102–105, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Google Scholar · View at Scopus
  18. W. C. Kershaw and C. D. Klaassen, “Degradation and metal composition of hepatic isometallothioneins in rats,” Toxicology and Applied Pharmacology, vol. 112, no. 1, pp. 24–31, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. W. J. Triggs and L. J. Willmore, “In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection,” Journal of Neurochemistry, vol. 42, no. 4, pp. 976–980, 1984. View at Google Scholar · View at Scopus
  20. A. Santamaria and C. Rios, “MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum,” Neuroscience Letters, vol. 159, no. 1-2, pp. 51–54, 1993. View at Google Scholar · View at Scopus
  21. M. Thiyagarajan and S. S. Sharma, “Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats,” Life Sciences, vol. 74, no. 8, pp. 969–985, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. L. L. Iversen and J. Glowinski, “Regional studies of catecholamines in the rat brain. II: rate of turnover of catecholamines in various brain regions,” Journal of Neurochemistry, vol. 13, no. 8, pp. 671–682, 1966. View at Google Scholar · View at Scopus
  23. G. Paxinos and C. Watson, The Rats Brain in Steritaxic Coordinates, Academic Press, San Diego, Calif, USA, 4th edition, 1998.
  24. M. Niyaz, T. Numakawa, Y. Matsuki et al., “MCI-186 prevents brain tissue from neuronal damage in cerebral infarction through the activation of intracellular signaling,” Journal of Neuroscience Research, vol. 85, no. 13, pp. 2933–2942, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Yu, J. Guo, H. Fang, and S. Peng, “Basal metallothionein-I/II protects against NMDA-mediated oxidative injury in cortical neuron/astrocyte cultures,” Toxicology, vol. 282, no. 1-2, pp. 16–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Prado, P. Pifarré, M. Giralt et al., “Metallothioneins I/II are involved in the neuroprotective effect of sildenafil in focal brain injury,” Neurochemistry International, vol. 62, no. 1, pp. 70–78, 2013. View at Google Scholar
  27. J. J. McAuliffe, B. Joseph, E. Hughes, L. Miles, and C. V. Vorhees, “Metallothionein I,II deficient mice do not exhibit significantly worse long-term behavioral outcomes following neonatal hypoxia-ischemia: MT-I,II deficient mice have inherent behavioral impairments,” Brain Research, vol. 1190, no. 1, pp. 175–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Méndez-Armenta, J. Villeda-Hernández, R. Barroso-Moguel, C. Nava-Ruíz, M. E. Jiménez-Capdeville, and C. Ríos, “Brain regional lipid peroxidation and metallothionein levels of developing rats exposed to cadmium and dexamethasone,” Toxicology Letters, vol. 144, no. 2, pp. 151–157, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. E. I. Christensen and H. Birn, “Megalin and cubilin: Multifunctional endocytic receptors,” Nature Reviews Molecular Cell Biology, vol. 3, no. 4, pp. 256–266, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. K. E. Lewis, R. S. Chung, A. K. West et al., “Distribution of exogenous metallothionein following intraperitoneal and intramuscular injection of metallothionein-deficient mice,” Histology and Histopathology, vol. 27, no. 11, pp. 1459–1470, 2012. View at Google Scholar
  31. J. H. Lee, H. S. Cui, S. K. Shin et al., “Effect of propofol post-treatment on blood-brain barrier integrity and cerebral edema after transient cerebral ischemia in rats,” Neurochemical Research, vol. 38, no. 11, pp. 2276–2286, 2013. View at Google Scholar